Pharmacological agents in development for diabetic macular edema.

International Journal of Retina and Vitreous
Mohammad Ali SadiqQuan Dong Nguyen

Abstract

Diabetic macular edema (DME) is the leading cause of visual loss in patients with diabetic retinopathy. There has been a paradigm shift in the treatment of DME since the advent of anti-vascular endothelial growth factor (anti-VEGF) therapy. The safety and efficacy of anti-VEGF therapy has been well established. Although efficacious, currently approved anti-VEGF agents are associated with certain limitations, which include, among others: frequent need for injections, high treatment cost and variable response to treatment. These challenges have led to an active search for more novel agents that may be able to overcome these limitations. The index review focuses on novel treatment agents that target various pathways in patients with DME. These agents are used either as monotherapy or in combination with other agents in the management of DME. Drugs discussed include novel anti-VEGF inhibitors, TIE-2 receptor modulators, integrin peptide inhibitors, rho kinase inhibitors, and future therapies such as neuroprotection and gene therapy. The future of investigational pharmacological therapy appears promising for patients with DME. Results from early clinical trials indicate that newer agents highlighted in the study may be safe and effi...Continue Reading

References

Apr 14, 2004·Archives of Ophthalmology·John H KempenUNKNOWN Eye Diseases Prevalence Research Group
May 21, 2004·Protein Science : a Publication of the Protein Society·Leila K MosaviZheng-Yu Peng
Nov 30, 2006·Journal of Cellular Physiology·Peter A Campochiaro
Jun 26, 2007·Microvascular Research·A AfzalM B Grant
Nov 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·John S RudgeGeorge D Yancopoulos
Feb 12, 2011·Investigative Ophthalmology & Visual Science·Sampathkumar RangasamyArup Das
Apr 5, 2011·Ophthalmology·Michael J ElmanUNKNOWN Diabetic Retinopathy Clinical Research Network
May 20, 2011·Nature·Peter Carmeliet, Rakesh K Jain
Feb 15, 2012·Ophthalmology·Quan Dong NguyenUNKNOWN RISE and RIDE Research Group
Oct 18, 2012·Investigative Ophthalmology & Visual Science·Quan Dong NguyenUNKNOWN DEGAS Clinical Study Group
Oct 30, 2012·Clinical Colorectal Cancer·Edith P Mitchell
Jun 7, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Fei WangXiaoxin Li
Jun 19, 2013·Free Radical Biology & Medicine·Mitsuo KatoRama Natarajan
Oct 5, 2013·International Journal of General Medicine·Mohamed Fath El-BabHesham A El-Beshbishy
Nov 5, 2013·Trends in Endocrinology and Metabolism : TEM·Rafael SimóUNKNOWN European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Dec 11, 2013·Therapeutic Advances in Endocrinology and Metabolism·David S BoyerJason S Ehrlich
Mar 29, 2014·Annals of the New York Academy of Sciences·Steven F Abcouwer, Thomas W Gardner
May 27, 2014·JAMA : the Journal of the American Medical Association·Jonathan Silver
Aug 12, 2014·The Lancet Global Health·Rupert R A BourneUNKNOWN Vision Loss Expert Group
Aug 16, 2014·Progress in Retinal and Eye Research·Ivana TrapaniAlberto Auricchio
Aug 17, 2014·Progress in Retinal and Eye Research·Rodolfo MastropasquaLeonardo Mastropasqua
Aug 20, 2014·Ophthalmology and Therapy·George Trichonas, Peter K Kaiser
Jan 7, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·João Rafael de Oliveira DiasEduardo Büchele Rodrigues
Feb 11, 2015·Investigative Ophthalmology & Visual Science·Debra A ThompsonUNKNOWN Monaciano Consortium
Feb 14, 2015·The British Journal of Ophthalmology·Ahmad M MansourMarwan E El-Sabban
Feb 25, 2015·Journal of Ophthalmic & Vision Research·Nasrollah Samiy
May 6, 2015·Progress in Retinal and Eye Research·Rafael Simó, Cristina Hernández
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·M ZhaoJ Xuan
Dec 15, 2015·Retina·Jay ChhablaniMichael Stewart
Dec 18, 2015·Journal for Immunotherapy of Cancer·Joanne A HammillJonathan L Bramson

❮ Previous
Next ❯

Citations

Dec 30, 2020·International Journal of Retina and Vitreous·Mohammad Ali SadiqQuan Dong Nguyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Diabetes Reports
Aniruddha AgarwalQuan Dong Nguyen
The Journal of Pharmacology and Experimental Therapeutics
Sónia Torres-CostaManuel Falcão
Expert Opinion on Emerging Drugs
Stephen G SchwartzIngrid U Scott
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
L Yang, J Zhang
© 2021 Meta ULC. All rights reserved